A personalized treatment plan recommendation method and system based on artificial intelligence
CN118280512BActive Publication Date: 2025-01-17TAIHAOLE BIOTECHNOLOGY CO LTD
Patent Information
- Application Number
- CN202410403998.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-05
- Publication Date
- 2025-01-17
- Estimated Expiration
- 2044-04-05
Smart Images

Figure CN118280512B_ABST
Abstract
The present invention provides a personalized treatment plan recommendation method and system based on artificial intelligence, which obtains patient disease data and patient basic data; uses a neural network to process the patient disease data to obtain therapeutic drugs, and screens the therapeutic drugs; obtains the dosage range of the therapeutic drugs according to the patient basic data; obtains rehabilitation indicators based on the patient disease data; uses the gray wolf optimization algorithm to optimize the dosage range based on the rehabilitation indicators, and obtains the patient's optimal medication dosage; determines the therapeutic drugs to be taken according to the disease suffered by the patient, and after screening the therapeutic drugs, obtains the dosage range of the therapeutic drugs and the rehabilitation indicators of the disease types respectively, and finally uses the gray wolf optimization algorithm to calculate the optimal medication dosage, so as to obtain the optimal dosage of the therapeutic drugs used to treat the patient's disease. Since the patient's own physical condition is taken into consideration, the absorption effect of the drugs can be guaranteed, and the normal progress of the disease treatment can be guaranteed.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Gamma knife radiotherapy reverse design planning method
CN103949015A
Clinical intelligent decision-making platform
CN110827951A